Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Co-transplantation in Allogeneic HSCT
NCT04247945Phase 3Recruiting
- Sponsor
- Fujian Medical University
- Start
- Feb 2020
- Primary completion
- Dec 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Provacel in graft-versus-host disease (GVHD), Graft failure, sponsored by Fujian Medical University. Started Feb 2020; status: recruiting.
02
Drugs
Provacel
03
Conditions
graft-versus-host disease (GVHD)Graft failure
Beyond the preview
Go deeper on NCT04247945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04247945.